Conditional Modulation of Membrane Protein Expression in Cultured Cells Mediated by Prion Protein Recognition of Short Phosphorothioate Oligodeoxynucleotides*
- Marcela Viviana Karpuj‡,1,
- Sagit Gelibter-Niv‡,
- Anat Tiran‡,
- Angelika Rambold§,2,
- Jörg Tatzelt§,3,
- Max Nunziante¶,3 and
- Hermann M. Schatzl¶‖,3
- From the ‡Institute of Biochemistry, Food Science and Nutrition Food and Environmental Quality Sciences, Faculty of Agriculture, Hebrew University of Jerusalem, Rehovot 76100, Israel,
- the §Department of Neurobiochemistry, Adolf-Butenandt-Institute, Ludwig-Maximilians-University Munich, 80336 Munich, Germany,
- the ¶Institute of Virology, Technical University of Munich, Trogerstrasse 30, D-81675 Munich, Germany, and
- the ‖Departments of Veterinary Sciences and of Molecular Biology, University of Wyoming, Laramie, Wyoming 82071
- 1 To whom correspondence should be addressed: 1378, 19th Ave., San Francisco, CA 94122. Fax: 415-665-1414; E-mail: mvkarpuj{at}gmail.com.
-
↵3 These authors contributed equally to this study.
Abstract
We demonstrate that the levels of native as well as transfected prion protein (PrP) are lowered in various cell lines exposed to phosphorothioate oligodeoxynucleotides (PS-DNA) and can be rapidly reverted to their normal amounts by removal of PS-DNA. This transient modulation was independent of the glycosylation state of PrP, and in addition, all three PrP glycoforms were susceptible to PS-DNA treatment. Deletion of the N-terminal domain (amino acids 23–99), but not of the other domains of PrP, abrogated its PS-DNA-mediated down-regulation. PrP versions localized in the mitochondria, cytoplasm, or nucleus were not modulated by PS-DNA, indicating that PrP surface exposure is required for executing this effect. Proteins that in their native forms were not responsive to PS-DNA, such as thymocyte antigen 1 (Thy1), Doppel protein (Dpl), green fluorescent protein (GFP), and cyan fluorescent protein (CFP), became susceptible to PS-DNA-mediated down-regulation following introduction of the N terminus of PrP into their sequence. These observations demonstrate the essential role of the N-terminal domain for promoting oligonucleotide-mediated reduction of the PrP level and suggest that transient treatment of cultured cells with PS-DNA may provide a general method for targeted modulation of the levels of desired surface proteins in a conditional and reversible manner.
Footnotes
-
↵* This work was supported by the Career Development Award Grant, Human Frontier Science Program (to M. V. K.), grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the BMBF (BioDisc, DIP5.1) (to J. T.), and grants from the Deutsche Forschungsgemeinschaft (SFB 596) and European Union NoE Neuroprion (to H. M. S.).
-
↵
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1–4.
- Received October 15, 2010.
- Revision received December 9, 2010.
- © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.











